Calibration-free NGS quantitation of mutations below 0.01% VAF.
Peng DaiLucia Ruojia WuSherry Xi ChenMichael Xiangjiang WangLauren Yuxuan ChengJinny Xuemeng ZhangPengying HaoWeijie YaoJabra ZarkaGhayas C IssaLawrence KwongDavid Yu ZhangPublished in: Nature communications (2021)
Quantitation of rare somatic mutations is essential for basic research and translational clinical applications including minimal residual disease (MRD) detection. Though unique molecular identifier (UMI) has suppressed errors for rare mutation detection, the sequencing depth requirement is high. Here, we present Quantitative Blocker Displacement Amplification (QBDA) which integrates sequence-selective variant enrichment into UMI quantitation for accurate quantitation of mutations below 0.01% VAF at only 23,000X depth. Using a panel of 20 genes recurrently altered in acute myeloid leukemia, we demonstrate quantitation of various mutations including single base substitutions and indels down to 0.001% VAF at a single locus with less than 4 million sequencing reads, allowing sensitive MRD detection in patients during complete remission. In a pan-cancer panel and a melanoma hotspot panel, we detect mutations down to 0.1% VAF using only 1 million reads. QBDA provides a convenient and versatile method for sensitive mutation quantitation using low-depth sequencing.
Keyphrases
- ms ms
- mass spectrometry
- liquid chromatography tandem mass spectrometry
- liquid chromatography
- high performance liquid chromatography
- tandem mass spectrometry
- solid phase extraction
- single cell
- label free
- loop mediated isothermal amplification
- optical coherence tomography
- end stage renal disease
- high resolution
- newly diagnosed
- chronic kidney disease
- simultaneous determination
- real time pcr
- prognostic factors
- genome wide
- systemic lupus erythematosus
- patient safety
- patient reported
- dna methylation
- patient reported outcomes